CAS: 2226-96-2; 2,2,6,6-Tetramethyl-4-Hydroxy-1-Piperidinyloxy Radical

相似化合物

95407-69-5 2896-70-0 2564-83-2

上下游产品

CAS号78119-82-1 6-羟基-2-萘甲醛 | CAS号760-93-0 甲基丙烯酸酐 | CAS号3637-10-3 4-羟基-2,2,6,6-四甲基哌啶氧 | CAS号132416-36-5 2,2,6,6-四甲基-1-(... | CAS号122586-72-5 1-methoxy-2,2,6... | CAS号87018-00-6 1-cyclohexyloxy... | CAS号290821-83-9 1-(2-hydroxy-2-...

四甲基哌啶酮置于sodium Tetrahydroborate,Sodium Tungstate (Vi) Dihydrate,双氧水体系中,用 甲醇,乙醇,水 用作溶剂,化学反应 56.0H,反应生成阻聚剂701
参考文献:2'-炔基核苷酸:Dna 中 Epr 光谱的序列和自旋标记灵活策略
标题:2'-炔基核苷酸:Dna 中 Epr 光谱的序列和自旋标记灵活策略
摘要:电子顺磁共振 (Epr) 光谱是一种通过测量构象明确定义的自旋标记之间的距离来阐明分子结构的强大方法.在这里,我们报告了一种序列灵活的方法来合成双自旋标记的 Dna 双链体,其中 2'-炔基核苷结合在互补链的末端和内部位置.Dna 合成后铜催化的叠氮化物-炔环加成 (Cuaac) 反应与各种自旋标记物能够使用双电子-电子共振实验来测量双链体上的多个距离,提供高水平的详细结构信息.
Doi:10.1021/jacs.6B05421

专利信息

专利号:US-12338202-B2
优先权日:2021-09-10
标 题 :One pot synthesis of urea (meth)acrylates
发明人：BESTGEN SEBASTIAN; BEYER SILVIA
权利人:EVONIK OPERATIONS GMBH
摘要:A one-pot synthesis of polymerizable and acyclic urea (meth)acrylates, preferably mono(meth)acrylates, can be performed via in-situ synthesis of urea alcohols or amines followed by direct reaction with a (meth)acrylate reactive diluent. The urea alcohol/amine is obtained from isocyanates and alcohols, amines, or hydroxyamines. Subsequently, the reaction with the (meth)acrylate reactive diluent takes place and the urea (meth)acrylate is directly obtained either in solution with the reactive diluent, or as a pure material after removal of the reactive diluent.

专利号:US-6329543-B1
优先权日:1999-05-06
标题:Process for synthesis of isobornyl (Meth) acrylate
发明人：KNEBEL JOACHIM; SAAL DORIS
权利人:ROEHM GMBH
摘要:The present invention relates to processes for synthesis of isobornyl (meth)acrylate by reacting camphene with (meth)acrylic acid in the presence of sulfuric acid and at least one compound having inhibiting action. Aqueous sulfuric acid with an acid concentration in the range of 65 to 85 wt % is used. Isobornyl (meth)acrylate can advantageously be distilled from a mixture containing sulfuric acid in the presence of 2,6-di-tert-butyl-alpha-(dialkylamino)-p-cresol.

专利号:WO-2005100367-A1
优先权日:2004-04-13
标 题 :Intermediates useful in the synthesis of 3-(2-substituted vinyl) cephalosporins
发明人：KUMAR YATENDRA; PRASAD MOHAN; SINGH KAPTAN; PRASAD ASHOK; RICHHARIYA SANTOSH
权利人:RANBAXY LAB LTD; KUMAR YATENDRA; PRASAD MOHAN; SINGH KAPTAN; PRASAD ASHOK; RICHHARIYA SANTOSH
摘要:The present invention relates to crystalline intermediates useful in the synthesis of 3-(2-substituted vinyl) cephalosporins and processes for their preparation. In particular, the present invention relates to crystalline ylides of Formula I, processes for their preparation, and their use as an intermediate in thepreparation of 3-(2-substituted vinyl) cephalosporins.

专利号:US-3674818-A
优先权日:1969-12-05
标 题:Synthesis of a material with juvenile hormone activity
发明人：LAW JOHN H
权利人:US HEALTH EDUCATION & WELFARE
摘要:Synthesis of a material with juvenile hormone activity by reacting crude or purified farnesoic acid with alcoholic hydrogen chloride wherein the alcohol is selected from the group consisting of ethanol, methanol, n-propanol and n-pentanol. Various comparisons are shown with other related compounds and an exemplary list of insects sensitive to the material is set forth.

专利号:US-7592392-B2
优先权日:2003-04-04
标 题 :Synthesis of functional polymers for use in organic synthesis and combinatorial chemistry
发明人：LINDSLEY CRAIG W; WISNOSKI DAVID D
权利人:MERCK & CO INC
摘要:The present invention relates to a novel process for the preparation of solid-supported scavenging reagents and solid-supported functional polymers. The invention further relates to novel solid-supported functional polymers and to their use in organic synthesis and combinatorial chemistry.

专利号:US-2008287407-A1
优先权日:2003-12-10
标题 :Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use
发明人：GARVEY DAVID S; FANG XINQIN; KHANAPURE SUBHASH P; RANATUNGA RAMANI R; WEY SHIOW-JYI
权利人:NITROMED INC
摘要:The invention describes novel nitrosated and/or nitrosylated pyruvate compounds and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated pyruvate compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one pyruvate compound and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one pyruvate compound, that is optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating diseases resulting from oxidative stress, diabetes, reperfusion injury following ischemia, preservation of tissues, organs, organ parts and/or limbs.